The first two authors, Folashade Otegbeye and Evelyn Ojo, should be noted as contributing equally to this work.
The following information is missing from the Funding section: This study was supported by NIH grant T32 GM007250 to EO.
Reference
- 1.Otegbeye F, Ojo E, Moreton S, Mackowski N, Lee DA, de Lima M, et al. (2018) Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models. PLoS ONE 13(1): e0191358 https://doi.org/10.1371/journal.pone.0191358 [DOI] [PMC free article] [PubMed] [Google Scholar]